It offers half the wait time compared to commercially available SCS systems with lead placements anywhere along the spine, Abbott said. Under the expanded labeling, Abbott’s Eterna SCS system offers faster scan times. Those surgeons want to accomplish this while still remaining capable of conducting an MRI scan anywhere on the body. This study also revealed that surgeons place a high value on the ability to implant leads in the epidural space. ![]() It also features normal operating mode scanning with select leads.Ībbott cited recent findings from its own study demonstrating that 93% of surgeons consider MRI accessibility an important to essential factor when determining the best SCS system for their patients. Eterna SCS with TotalScan MRI now provides fully-body MRI capabilities. It means people with chronic pain can undergo MRI scans within approved, outlined conditions with a wider selection of lead options for full-body scans. The expanded labeling includes new leads that are MR (magnetic resonance) conditional. In addition, it allows the physicians to control multiple independent BurstDR stimulation areas to provide a wider pain coverage, eliminating the risk of overstimulation, said Abbott.The Eterna spinal cord stimulation (SCS) system Abbott (NYSE:ABT) announced today that the FDA approved expanded MRI labeling for its Eterna spinal cord stimulation (SCS) system. The company said that its FlexBurst360 therapy, delivered through the Proclaim Plus system, will help physicians identify the lowest effective dose of stimulation for each patient, and adjust the simulation based on evolving pain needs. In the trials, 87% of people preferred BurstDR technology, said Abbott. Unlike other tonic stimulation technology, which provides a tingling sensation felt by the patient, BurstDR offers pain relief in a sub-sensory range, which is not felt by the patient. In the clinical trials, BurstDR therapy delivered superior pain relief compared to tonic stimulation, and improved the quality of life, and reduced the emotional suffering dur to pain. ![]() “Our latest development, Proclaim Plus with FlexBurst360 therapy, is yet another testament of that commitment.”īurstDR is a stimulation technology that delivers pulses, or bursts of mild electrical energy to alter pain signals as they travel from the spinal cord to the brain. It can be used with its NeuroSphere Virtual Clinic connected care technology, which facilitates secure in-app video chat with physician and remote stimulation settings.Ībbott neuromodulation vice president Pedro Malha said: “At Abbott, we are deeply committed to advancing the field of neurostimulation, thus helping people address the challenges they face while managing their chronic pain. It works to relieve pain across up to six areas in the trunk and limbs, and enables programming to adjust the settings as per the patient’s therapeutic needs.Ībbott designed the new Proclaim Plus SCS system to be recharge-free, featuring a battery that can last up to 10 years. The US medical device maker developed FlexBurst360 therapy based on its unique BurstDR stimulation that works by mimicking natural patterns of the brain to relieve pain. The new Proclaim Plus spinal cord stimulation (SCS) system can be used in conjunction with Abbott's NeuroSphere Virtual Clinic, which allows people to connect with their doctor and receive remote programming adjustmentsĪbbott has secured the US Food and Drug Administration (FDA) approval for its new Proclaim Plus spinal cord stimulation (SCS) system to deliver FlexBurst360 therapy.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |